Perioperative nivolumab monotherapy versus nivolumab plus ipilimumab in resectable hepatocellular carcinoma: a randomised, open-label, phase 2 trial
収録刊行物
-
- The Lancet Gastroenterology & Hepatology
-
The Lancet Gastroenterology & Hepatology 7 (3), 208-218, 2022-03
Elsevier BV